-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
-
Summary
-
Sonnet BioTherapeutics Holdings, Inc. annual/quarterly Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate from 2017 to 2024.
- Sonnet BioTherapeutics Holdings, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending December 31, 2023 was $18.6K, a 50% decline year-over-year.
- Sonnet BioTherapeutics Holdings, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the twelve months ending December 31, 2023 was $129K, a 49.8% decline year-over-year.
- Sonnet BioTherapeutics Holdings, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2024 was $18.6K, a 87.4% decline from 2023.
- Sonnet BioTherapeutics Holdings, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2023 was $148K, a 57.8% decline from 2022.
- Sonnet BioTherapeutics Holdings, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2022 was $350K, a 27.6% decline from 2021.
Revenue from Contract with Customer, Excluding Assessed Tax, Trailing 12 Months (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, Annual (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Annual Growth (%)